Occurrence of implantable defibrillator events in patients with syncope and nonischemic dilated cardiomyopathy

American Journal of Cardiology

Volumn 88, Issue 12, 2001, Pages 1444-1446

  Russo, Andrea M ^a,b   Verdino, Ralph ^a   Schorr, Christa ^a   Nicholas, Maureen ^a   Dias, Darryl ^a   Hsia, Henry ^a   Callans, David ^a   Marchlinski, Francis E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b PENN PRESBYTERIAN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INOTROPIC AGENT; QUINIDINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEFIBRILLATOR; DISEASE COURSE; EVALUATION; FEMALE; FOLLOW UP; HEART DILATATION; HEART ELECTROPHYSIOLOGY; HEART VENTRICLE ARRHYTHMIA; HUMAN; IMPLANTATION; MALE; PRIORITY JOURNAL; PROGNOSIS; SUDDEN DEATH; SYNCOPE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARDIOMYOPATHY, DILATED; DEFIBRILLATORS, IMPLANTABLE; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; HUMANS; MALE; MIDDLE AGED; SYNCOPE;

EID: 0035893267     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(01)02133-6     Document Type: Article

References (14)

1. Syncope in advanced heart failure: High risk of sudden death regardless of origin of syncope
2. Syncope in dilated cardiomyopathy is a predictor of sudden cardiac death
3. Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia
4. Electrophysiological evaluation of sustained ventricular tachyarrhythmias in idiopathic dilated cardiomyopathy
5. The response of patients with complex ventricular arrhythmias secondary to dilated cardiomyopathy to programmed electrical stimulation
6. Role of programmed ventricular stimulation in patients with idiopathic dilated cardiomyopathy and documented sustained ventricular tachyarrhythmias: Inducibility and prognostic value in 102 patients
7. Shock occurrence and survival in 49 patients with idiopathic dilated cardiomyopathy and an implantable cardioverter-defibrillator
8. Outcome of patients with non-ischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator
9. Improved survival in patients with nonischemic advanced heart failure and syncope treated with an implantable cardioverter-defibrillator
10. Long-term follow-up of patients with nonischemic dilated cardiomyopathy, and ventricular tachyarrhythmias treated with implantable cardioverter defibrillators
11. Implantable defibrillator event rates in patients with unexplained syncope and inducible sustained ventricular tachyarrhythmias
12. High incidence of appropriate implantable cardioverter-defibrillator therapy in patients with syncope of unknown etiology and inducible ventricular arrhythmias
13. Long-term outcome of patients with unexplained syncope treated with an electrophysiologic-guided approach in the implantable cardioverter-defibrillator era
14. Implantable cardioverter defibrillator utilization among device recipients presenting exclusively with syncope or near-syncope